Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease
Clear cell renal cell carcinoma (ccRCC) displays a highly varying clinical progression, from slow growing localized tumors to very aggressive metastatic disease (mRCC). Almost a third of all patients with ccRCC show metastatic dissemination at presentation while another third develop metastasis duri...
Main Authors: | Harini Lakshminarayanan, Dorothea Rutishauser, Peter Schraml, Holger Moch, Hella A. Bolck |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.582843/full |
Similar Items
-
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
by: Florian Büttner, et al.
Published: (2018-07-01) -
Heterogeneity and renal mass biopsy: a review of its role and reliability
by: Jeffrey J. Tomaszewski, et al.
Published: (2014-09-01) -
TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients’ survival
by: Xiao W, et al.
Published: (2018-11-01) -
Metastatic renal cell carcinoma in the thyroid gland
by: Mark M. Cruz, et al.
Published: (2020-11-01) -
Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
by: Liangsong Zhu, et al.
Published: (2019-07-01)